100 related articles for article (PubMed ID: 12532)
1. Treatment of obsessive compulsive neurosis: pharmacological approach.
Ananth J
Psychosomatics; 1976; 17(4):180-4. PubMed ID: 12532
[No Abstract] [Full Text] [Related]
2. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
3. A double-blind test on the effect of bromazepam in obsessive-compulsive neurosis.
Lin HN; Chen CC
Taiwan Yi Xue Hui Za Zhi; 1979 Mar; 78(3):267-75. PubMed ID: 35583
[No Abstract] [Full Text] [Related]
4. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
Teeuwisse JM; Nolen WA
Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
[No Abstract] [Full Text] [Related]
5. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
Ferren T; Palmes GK; Kaplan SG
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
[No Abstract] [Full Text] [Related]
6. Obsessive-compulsive disorder: a treatment review.
Perse T
J Clin Psychiatry; 1988 Feb; 49(2):48-55. PubMed ID: 2892831
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of Bromazepam with special reference to obsessive syndromes and phobias].
De Giacomo P; Pierri G
Acta Neurol (Napoli); 1974; 29(3):307-13. PubMed ID: 4153901
[No Abstract] [Full Text] [Related]
8. [Antidepressive agents in the treatment of obsessive-compulsive disorder].
Hansen ES; Bolwig TG
Ugeskr Laeger; 1997 Jan; 159(2):183-4. PubMed ID: 9012092
[No Abstract] [Full Text] [Related]
9. Serotonergic antidepressants and obsessive-compulsive disorder.
Cialdella P; Boissel JP
Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
[No Abstract] [Full Text] [Related]
10. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
[No Abstract] [Full Text] [Related]
11. [A new therapeutic principle in mania].
Gross H; Kaltenbäck E
Wien Med Wochenschr; 1966 Dec; 116(50):1102-6. PubMed ID: 5340056
[No Abstract] [Full Text] [Related]
12. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Kamijima K; Aoki M
Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough in psychiatric care. Pharmacological treatment of obsessive-compulsive disorders with implications for nursing care.
Giger JN; Davidhizar R; Poole VL; Malone SB
J Pract Nurs; 2000 Mar; 50(1):23-8; quiz 29-31. PubMed ID: 11951236
[No Abstract] [Full Text] [Related]
14. Management of obsessive-compulsive disorder.
Veale D
Br J Hosp Med; 1990 Apr; 43(4):278-81. PubMed ID: 2189520
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the use of antidepressant and anxiolytic medications.
Simeon JG; Ferguson HB
Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
[TBL] [Abstract][Full Text] [Related]
16. [Obsessions and mood: apropos of 43 cases of obsessive neurosis treated with antidepressive chemotherapy and electroshock].
Dubois JC
Ann Med Psychol (Paris); 1984 Jan; 142(1):141-51. PubMed ID: 6476671
[No Abstract] [Full Text] [Related]
17. Psychopharmacologic treatment of obsessive-compulsive disorder.
Thorneloe WF
J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
[No Abstract] [Full Text] [Related]
18. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
Servant D; Bailly D; Le Seac'h H; Parquet PJ
Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
[TBL] [Abstract][Full Text] [Related]
19. Biological factors in obsessive-compulsive disorders.
Turner SM; Beidel DC; Nathan RS
Psychol Bull; 1985 May; 97(3):430-50. PubMed ID: 2860681
[No Abstract] [Full Text] [Related]
20. Anafranil in obsessive compulsive neurosis.
Wyndowe J; Solyom L; Ananth J
Curr Ther Res Clin Exp; 1975 Nov; 18(5):611-7. PubMed ID: 812637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
